Last week the FDA posted a recall notice on its website, notifying healthcare providers that the maker of the Nebion HLX-8 Magnetic Resonance Device had made unsupported claims. The marketing folks behind this product apparently believed it possessed quasi-magical powers.
Last week the FDA posted a recall notice on its website, notifying healthcare providers that the maker of the Nebion HLX-8 Magnetic Resonance Device had made unsupported claims. The marketing folks behind this product apparently believed it possessed quasi-magical powers.
From its single-pole mount several feet above floor level, this tube-like device, reminiscent of an oversized thermos bottle, had the power to treat breast, bone, lung, and pancreatic cancers, carpal tunnel syndrome, migraines, premenstrual syndrome, rheumatoid arthritis, ruptured disks, and shingles, according to its developers.
The device was not approved by the FDA, according to the agency's recall notice. It not only lacked safety and effectiveness data, but "was not manufactured under current good manufacturing practices," according to the FDA website.
I doubt that anyone with any degree of common sense, much less a medical degree, would have even used this device. Some, however, did buy the product. The FDA obtained a list of customers from the Los Angeles-based company and, in July, mailed a recall letter to each, asking them to immediately stop using the device.
The class 1 recall issued for the Nebion HLX-8 is reserved for devices that involve situations in which there is a reasonable probability that use of the product will cause serious injury or death, according to the FDA. The fact that the FDA issued a recall, however, can create a problem in itself.
Take, for example, the law offices of Robert H. Weiss, which apparently mistook the HLX-8 for an MR scanner. On the offices' website, they state that "if you or a loved one were imaged by Nebion's HLX-8 Magnetic Resonance Device...you may have a right to be compensated."
Quack medicine has been a problem in the U.S. for almost as long as our country has been around. Past gizmos have run the gamut from electropathy devices in the late 19th century that purported to cure mental illness to the MacGregor Rejuvenator, which in the 1930s used magnetism, radio waves, and infrared and ultraviolet rays to reverse the aging process. Because enough valid medical devices today use one or more of these technologies there is the real possibility the public will confuse a quack device for one that has clinical value.
There is no cure for quack medicine, and the FDA has to use the tools at its disposal to minimize its prevalence. We would do well, however, to be tuned into the downside of both.
Stay at the forefront of radiology with the Diagnostic Imaging newsletter, delivering the latest news, clinical insights, and imaging advancements for today’s radiologists.
Large Medicare Study Shows Black Men Less Likely to Receive PET and MRI for Prostate Cancer Imaging
August 3rd 2025An analysis of over 749,000 Medicare beneficiaries diagnosed with prostate cancer over a five-year period found that Black men were 13 percent less likely to receive PET imaging and 16 percent less likely to receive MRI in comparison to White men.
The Reading Room Podcast: Current and Emerging Insights on Abbreviated Breast MRI, Part 3
August 3rd 2025In the last of a three-part podcast episode, Stamatia Destounis, MD, Emily Conant, MD and Habib Rahbar, MD, share additional insights on practical considerations and potential challenges in integrating abbreviated breast MRI into clinical practice, and offer their thoughts on future research directions.
The Reading Room Podcast: A Closer Look at Remote MRI Safety, Part 3
August 3rd 2025In the third of a three-part podcast episode, Emanuel Kanal, M.D. and Tobias Gilk, MRSO, MRSE, discuss strategies for maintaining the integrity of time-out procedures and communication with remote MRI scanning.
Study Reveals Significant Prevalence of Abnormal PET/MRI and Dual-Energy CT Findings with Long Covid
August 3rd 2025In a prospective study involving nearly 100 patients with Long Covid, 57 percent of patients had PET/MRI abnormalities and 90 percent of the cohort had abnormalities on dual-energy CT scans.